Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis

• Published in: Acta diabetologica Vol. 58; no. 8; pp. 975 - 981
• Main Authors: Gallieni, Maurizio, De Salvo, Cristina, Lunati, Maria Elena, Rossi, Antonio, D’Addio, Francesca, Pastore, Ida, Sabiu, Gianmarco, Miglio, Roberta, Zuccotti, Gian Vincenzo, Fiorina, Paolo
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 01.08.2021; Springer Nature B.V
• Subjects: Blood glucose; Diabetes; Diabetes mellitus (non-insulin dependent); End-stage renal disease; Glucose; Glucose monitoring; Hemodialysis; Hemoglobin; Insulin; Internal Medicine; Kidney diseases; Medicine; Medicine & Public Health; Metabolic Diseases; Oscillations; Review; Review Article; Sensitivity analysis; Therapeutic targets; Continuous glucose monitoring; Chronic kidney disease; Hemodialysis; Diabetes mellitus
• ISSN: 0940-5429; 1432-5233; 1432-5233
• DOI: 10.1007/s00592-021-01699-6

Diabetic kidney disease is the leading cause of end-stage kidney disease in high-income countries. The strict control of glycemic oscillations is the principal therapeutic target, but this could be hard to achieve in uremic patients due to their unpredictable insulin sensitivity. Currently, the evaluation of the glycemic profile relies on serum markers (glycated hemoglobin HbA1c, glycated albumin, and fructosamine), capillary glucose blood control (self-monitoring of blood glucose), and interstitial glucose control (continue glucose monitoring). We conducted a systematic review of published articles on continue glucose monitoring in hemodialysis patients with type 2 diabetes, which included 12 major articles. Four studies found significant fluctuations in glucose levels during hemodialysis sessions. All studies reported a higher mean amplitude of glucose variations on the hemodialysis day. Three studies agreed that continue glucose monitoring is better than glycated hemoglobin in detecting these abnormalities. Moreover, continue glucose monitoring was more accurate and perceived as easier to use by patients and their caregivers. In patients with type 2 diabetes on hemodialysis, glucose levels show different variation patterns than the patients on hemodialysis without diabetes. Considering manageability, accuracy, and cost-effectiveness, continue glucose monitoring could be the ideal diagnostic tool for the patient with diabetes on hemodialysis.